Global Preimplantation Genetic Testing Market with Key Players Analysis, Trends and Growth Forecast till 2022

Fact.MR Fact.MR

Dublin 2, Ireland, 2018-May-21 — /EPR Network/ — Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth of preimplantation genetic testing market. The study is titled as Preimplantation Genetic Testing Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022”, which deeply analyses the global market trends, with historical data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2017-2022. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the global preimplantation genetic testing market.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=292

According to the latest report by Fact.MR, the global market for preimplantation genetic testing is expected to experience strong growth. The market is estimated to reach US$ 575.0 million revenue by 2022 end. Due to the increasing awareness of preimplantation genetic testing to avoid genetic disorders, the rise in a number of healthcare providers and healthcare institutes providing preimplantation genetic testing are the influencing factors contributing to the tremendous growth of the preimplantation genetic testing across the globe.

3 Forecast Highlights on Global Preimplantation Genetic Testing Market

1. North America is likely to emerge as the biggest market in the global preimplantation genetic testing. North America preimplantation genetic testing market is projected to surpass US$ 200 million by the end of 2022. Increasing adoption of innovative technologies and rising awareness about preimplantation genetic testing to avoid various birth defects among babies are some of the factors fueling the market growth in the region.

2. Europe is expected to be the second most lucrative market for preimplantation genetic testing. Owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government is driving the growth of preimplantation genetic testing in Europe.

3. A genetic screening test is likely to emerge as one of the most preferred test types in the global preimplantation genetic testing market. By the end of 2022, Genetic screening is projected to surpass US$ 300 million revenue.

Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy

Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.

NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market

Compared to the various other technologies, NGS is expected to be the technology gaining highest revenue share in the global preimplantation genetic testing market. NGS is estimated to exceed US$ 200 million revenue by 2022 end.

Genetic Screening to Emerge as the Highly Preferred Test Type

Genetic screening is expected to be the highly preferred test type as compared to genetic diagnosis. Gaining nearly two-third of the share in terms of revenue towards 2017 end, genetic screening is estimated to create more than US$ 100 million incremental opportunity throughout the forecast period.

Specialized Clinics to Account for Maximum Share

Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth throughout the forecast period.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global preimplantation genetic testing market through 2022, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.

Browse Full Report with TOC- https://www.factmr.com/report/292/preimplantation-genetic-testing-market

Table of Content:

1. Global Preimplantation Genetic Testing Market – Executive Summary

2. Global Preimplantation Genetic Testing Market Overview
2.1. Introduction
2.1.1. Global Preimplantation Genetic Testing Market Taxonomy
2.1.2. Global Preimplantation Genetic Testing Market Definition
2.2. Global Preimplantation Genetic Testing Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Preimplantation Genetic Testing Market Y-o-Y Growth
2.3. Global Preimplantation Genetic Testing Market Dynamics
2.4. Supply Chain
2.5. Cost Structure
2.6. Pricing Analysis
2.7. Raw Material Sourcing Strategy and Analysis
2.8. Service Provider List
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Preimplantation Genetic Testing Market Analysis and Forecast By Test Type 
3.1. Global Preimplantation Genetic Testing Market Size and Forecast By Test Type, 2012-2022
3.1.1. Genetic Diagnosis Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Genetic Screening Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region

Continued………

Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=292

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
Get More Industry Insights At: https://www.linkedin.com/company/factmr

Matched content

Editor’s pick

Express Press Release Distribution